Navigation Links
Healthy heart oats available: so indulge.

Oats are very important constituents of foods in the cereal category as they provide fibre beta glucan to the diet.

It is an integral part of health-conscious consumers. So there is news to cheer now as they can now// get more of the soluble oat fiber called beta-glucan in their diets. This variety of oats has been developed by Agricultural Research Service (ARS) and North Dakota State University (NDSU) scientists.

Beta-glucan can help lower blood levels of so-called "bad" cholesterol therefore oats are useful in diet. They diminish the risk of heart disease.

"HiFi," is the new variety of oats developed and it is a new spring oat bred specifically for increased beta-glucan content.

HiFi boasts 50 percent more beta-glucan than whole-oat products now sold in grocery stores said Doug Doehlert, a cereal chemist with ARS' Red River Valley Agricultural Research Center in Fargo, N.D

It can be interpreted as a consumer could eat less of a whole-oat product made with HiFi to get the same health benefit.

The oat also had good agronomic characteristics and excellent disease resistance, so its seed was made available for production in the northern Plains region. There, farmers grow oats primarily to feed livestock, and they prefer varieties with high fat content rather than high fibre.

So it is an important constituent for breakfast cereals and provides better health benefit.


'"/>




Page: 1

Related medicine news :

1. Want a Healthy brew? Have some Tea!
2. Healthy Medicine Or Harmful Intoxicant?
3. Healthy snacks improve nutrition of kids
4. Healthy ways to eat nourishing food
5. Helping Kids Attain a Healthy Weight
6. Counting Calories Might Be The Ideal Way To Stay Healthy
7. The Positive Effects Of A Healthy Lifestyle
8. The Positive Effects Of A Healthy Lifestyle
9. Reducing Disabilities By Following A Healthy Diet
10. Healthy Feeding Guidelines for Children Ages 0 to 24 Months Issued
11. Cobblestone Walking May Be The Key For Healthy Living.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... PHILADELPHIA (PRWEB) , ... July 24, 2017 , ... ... Health , two organizations that already work hand-in-hand on an Innovation Collaboration program, ... transform the access, quality, experience and cost of the care members and patients ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... (adipose) transfer systems announces the issuance of United States Patent Number 9,695,398 (the ... adipose filtration technology. The '398 and '324 patents cover methods and systems ...
(Date:7/24/2017)... ... 24, 2017 , ... The 2017 NCSL International Workshop & ... focuses on the new ISO/IEC 17025 standards. This marks the first time in ... calibration will be changed. , As an exhibitor, METTLER TOLEDO will showcase ...
(Date:7/24/2017)... ... July 24, 2017 , ... A ... focused on delivering end-to-end sleep health care at scale, indicates record-breaking adherence ... that adherence rates for positive airway pressure (PAP) therapy, the most widely utilized ...
(Date:7/24/2017)... Calif. (PRWEB) , ... July 24, 2017 , ... A ... from food addiction to sexual abuse, and how she has overcome them. “Forbidden Memories: ... instances in her life and how she has risen above. , In “Memories,” readers ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... York City-based market research firm Kalorama Information notes seven trends ... new products to new costs, to the threat of generic ... Potential Pipeline Disruptors . Among them are ... Age-Driven Growth - True Impact Moment Arriving   ... growing population and, to a more extreme extent, the aging ...
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
Breaking Medicine Technology: